Cornerstone Planning Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$109K Sell
207
-32
-13% -$15.4K 0.01% 235
2026
Q1
$111K Buy
239
+44
+23% +$23.9K 0.01% 232
2025
Q4
$119K Buy
195
+173
+786% +$97.8K 0.02% 194
2025
Q3
$1.75K Sell
22
-156
-88% -$72.6K ﹤0.01% 1195
2025
Q2
$83K Buy
178
+55
+45% +$23K 0.02% 167
2025
Q1
$53.1K Buy
123
+63
+105% +$34.1K 0.01% 226
2024
Q4
$35K Sell
60
-11
-15% -$6.05K 0.01% 233
2024
Q3
$38.9K Buy
71
+9
+15% +$5.33K 0.01% 216
2024
Q2
$37.1K Sell
62
-19
-23% -$10.9K 0.01% 233
2024
Q1
$46.4K Sell
81
-120
-60% -$67.3K 0.01% 182
2023
Q4
$107K Buy
201
+20
+11% +$9.68K 0.04% 115
2023
Q3
$91.6K Buy
181
+109
+151% +$58.1K 0.03% 118
2023
Q2
$37.6K Buy
+72
New +$38.9K 0.01% 298
2022
Q4
$38.5K Buy
+66
New +$35K 0.02% 307

Other funds holding TMO

Cornerstone Planning Group's TMO Position: Q2 2026 in Review

Cornerstone Planning Group reduced its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, selling an estimated $15.4K and leaving 207 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #235.

Cornerstone Planning Group first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $119K in Q4 2025. 1,625 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cornerstone Planning Group held 207 shares of Thermo Fisher Scientific worth $109K as of Q2 2026.
  • Cornerstone Planning Group sold 32 Thermo Fisher Scientific shares in Q2 2026, an estimated $15.4K.
  • Thermo Fisher Scientific made up 0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #235 holding.
  • Cornerstone Planning Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's Thermo Fisher Scientific position peaked at $119K in Q4 2025.
  • 1,625 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.